Search results
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 1 month agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 7 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Sanofi's (SNY) Dupixent Gets Europe Nod for Prurigo Nodularis
Zacks via Yahoo Finance· 2 years agoSanofi SNY and partner Regeneron REGN announced that the European Commission (EC) approved their...
Regeneron (REGN), Sanofi's Dupixent Gets Label Update in US
Zacks via Yahoo Finance· 5 months agoThe FDA updates Regeneron (REGN) and Sanofi's Dupixent label in the United States to include...
Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
Zacks via Yahoo Finance· 2 years agoSanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis
Zacks via Yahoo Finance· 1 year agoThe CHMP recommends approval of Sanofi (SNY) and partner Regeneron's Dupixent for the treatment of...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung",...
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 7 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
Zacks via Yahoo Finance· 2 years agoDupixent has become the key top-line driver for Sanofi (SNY). Sanofi possesses a leading vaccine...
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma...
Benzinga via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) announced results from a...